Literature DB >> 1537919

Comprehensive approach to identification of serovars of Mycobacterium avium complex.

J C Denner1, A Y Tsang, D Chatterjee, P J Brennan.   

Abstract

Serotyping of nontuberculous mycobacteria, especially those of the Mycobacterium avium complex, provides important epidemiological information, particularly in tracing origins of infections. Seroagglutination with whole cells and polyclonal rabbit antibodies was the original way of identifying serovars and is still commonly used. The discovery of the glycolipid nature of the typing antigens allows differentiation of serovars on the basis of thin-layer chromatography of whole antigens and gas chromatography-mass spectrometry of the characteristic sugars of the oligosaccharide haptens of these antigens. In particular, the generation of monoclonal antibodies to the glycolipid antigens allows facile differentiation of serovars through enzyme-linked immunosorbent assay. All of these protocols were applied in developing a comprehensive approach to the typing of members of the M. avium complex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537919      PMCID: PMC265080          DOI: 10.1128/jcm.30.2.473-478.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Structural studies on the type-specific antigens and lipids of the mycobacterium avium. Mycobacterium intracellulare. Mycobacterium scrofulaceum serocomplex. Mycobacterium intracellulare serotype 9.

Authors:  P J Brennan; M B Goren
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  The 7H11 medium for the cultivation of mycobacteria.

Authors:  M L Cohn; R F Waggoner; J K McClatchy
Journal:  Am Rev Respir Dis       Date:  1968-08

Review 3.  Mycobacterium avium complex infection.

Authors:  L S Young
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

4.  The seroagglutination test in the study of nontuberculous mycobacteria.

Authors:  J K McClatchy
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

5.  Whole chromosomal DNA probes for rapid identification of Mycobacterium tuberculosis and Mycobacterium avium complex.

Authors:  M C Roberts; C McMillan; M B Coyle
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

6.  Production and characterization of monoclonal antibodies against specific serotypes of Mycobacterium avium and the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex.

Authors:  A H Kolk; R Evers; D G Groothuis; H Gilis; S Kuijper
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

7.  Direct identification of Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium intracellulare from amplified primary cultures in BACTEC media using DNA probes.

Authors:  E M Peterson; R Lu; C Floyd; A Nakasone; G Friedly; L M de la Maza
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

8.  Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome.

Authors:  M A Yakrus; R C Good
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  Concentration of Mycobacterium avium by hospital hot water systems.

Authors:  G C du Moulin; K D Stottmeier; P A Pelletier; A Y Tsang; J Hedley-Whyte
Journal:  JAMA       Date:  1988-09-16       Impact factor: 56.272

10.  Enzyme-linked immunosorbent assay of glycolipid antigens for identification of mycobacteria.

Authors:  D L Yanagihara; V L Barr; C V Knisley; A Y Tsang; J K McClatchy; P J Brennan
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

View more
  12 in total

1.  Caring for pets of immunocompromised persons.

Authors:  F J Angulo; C A Glaser; D D Juranek; M R Lappin; R L Regnery
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

2.  Niacin-positive Mycobacterium kansasii isolated from immunocompromised patients.

Authors:  I Nachamkin; R R MacGregor; J L Staneck; A Y Tsang; J C Denner; M Willner; S Barbagallo
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients.

Authors:  Ryoji Maekura; Yoshinari Okuda; Atsusi Hirotani; Seigo Kitada; Touru Hiraga; Kenji Yoshimura; Ikuya Yano; Kazuo Kobayashi; Masami Ito
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Comparative evaluation of PCR and commercial DNA probes for detection and identification to species level of Mycobacterium avium and Mycobacterium intracellulare.

Authors:  A Devallois; M Picardeau; K S Goh; C Sola; V Vincent; N Rastogi
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  Differentiation of mycobacteria on the basis of chemotype profiles by using matrix solid-phase dispersion and thin-layer chromatography.

Authors:  M E Hines; K S Frazier
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

6.  Serovars of Mycobacterium avium complex isolated from patients in Denmark.

Authors:  D S Askgaard; S B Giese; S Thybo; A Lerche; J Bennedsen
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

7.  Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245.

Authors:  J Bauer; A B Andersen; D Askgaard; S B Giese; B Larsen
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 8.  Mycobacterium avium complex: advances in therapy.

Authors:  D V Havlir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

9.  Genetic characterization of Mycobacterium avium isolates recovered from humans and animals in Australia.

Authors:  M M Feizabadi; I D Robertson; D V Cousins; D Dawson; W Chew; G L Gilbert; D J Hampson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

10.  Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine.

Authors:  S T Brown; F F Edwards; E M Bernard; W Tong; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.